MLN2238: Proteasome β5 Inhibitor Workflow
2026-08-11
MLN2238 enables controlled chymotrypsin-like proteasome inhibition for apoptosis, proteotoxic-stress, multiple myeloma, and lymphoma research. This practical guide combines dose–response design, reversible-exposure workflows, resistance studies, and ROS/JNK/CREB readouts inspired by a key Drosophila and 293T study.
ETS1–SENP2–HSPA8–FUNDC1 Axis in BPD
2026-08-10
The reference study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-induced bronchopulmonary dysplasia by controlling the SENP2/HSPA8/FUNDC1 mitophagy axis. Its findings connect FUNDC1 SUMO1 de modification, HSPA8 binding, and mitochondrial quality control, while also defining important limits for translating this mechanism beyond experimental BPD models.
Diethylmaleate Workflows for Redox Research
2026-08-09
Build controlled glutathione-depletion experiments with Diethylmaleate for oxidative stress, GST, and pesticide-resistance studies. This practical guide connects stock preparation, assay controls, and troubleshooting to findings from a Megalurothrips usitatus resistance model.
Bromodomain Inhibitor (+)-JQ1: Applied Workflows
2026-08-08
Bromodomain Inhibitor, (+)-JQ1 enables mechanism-led studies of BRD4, apoptosis, EMT, inflammation, and BRDT biology. This practical guide translates BET inhibition into dose planning, combination assays, pathway readouts, and troubleshooting strategies.
Trichostatin A: From Chromatin to Translation
2026-08-07
Trichostatin A (TSA) is more than a laboratory HDAC inhibitor: it is a reversible chromatin perturbation tool that can connect histone acetylation, differentiation, cell-cycle control, and combination treatment design. This article examines how TSA supports epigenetic regulation in cancer research, interprets evidence from a pancreatic ductal adenocarcinoma screen, and outlines a disciplined path from cell assays to in vivo validation.
Double-Positive Feedback Between AMPK and SQSTM1 in Metaboli
2026-08-07
This study reveals a novel double-positive feedback loop between AMPK and SQSTM1/p62 during metabolic stress, leading to the dual activation of AMPK and NFE2L2/NRF2 and enhancing antioxidant defenses. These findings advance our understanding of tumor adaptation mechanisms and suggest new avenues for targeting metabolic vulnerabilities in cancer.
Bismuth Subsalicylate: Precision Modulation of GI Membrane D
2026-08-06
Explore how Bismuth Subsalicylate enables precise study of gastrointestinal membrane dynamics, bridging inflammation pathway modulation and advanced apoptosis detection. This article offers a unique, mechanism-focused analysis distinct from existing content.
KPT-330 (Selinexor): Redefining Nuclear Export in Cancer Res
2026-08-06
Explore how KPT-330 (Selinexor) is revolutionizing translational cancer research by targeting nuclear export via CRM1 inhibition. This thought-leadership article blends mechanistic insight, evidence-based strategy, and actionable guidance for researchers seeking to overcome chemoresistance and drive new therapeutic frontiers.
Suhuang Capsule Inhibits ER Stress and NLRP3 in Cough Varian
2026-08-05
The reference study reveals how Suhuang antitussive capsule ameliorates pulmonary dysfunction in cough variant asthma by suppressing endoplasmic reticulum (ER) stress and inhibiting NLRP3 inflammasome activation. These mechanistic insights clarify the connection between ER stress modulation and airway inflammation, supporting more targeted approaches to respiratory disease intervention.
QX77 Molecular Chaperone Activator: Protocols & Advanced Use
2026-08-05
QX77 enables targeted upregulation of LAMP2A and Rab11, uniquely empowering researchers to dissect chaperone-mediated autophagy and drive stem cell differentiation. This guide translates the latest mechanistic insights and practical protocols into actionable strategies for autophagy pathway modulation and troubleshooting in advanced cellular research.
Camptothecin: Precision Tool for DNA Damage, Mutagenesis & A
2026-08-04
Explore how Camptothecin, a leading topoisomerase I inhibitor, uniquely enables precise DNA damage induction and advanced studies of adaptive mutagenesis. This article integrates recent prion-based epigenetic insights to guide optimal experimental strategies in cancer biology and genome stability research.
QX77: Molecular Chaperone Activator for Autophagy Research
2026-08-04
QX77 empowers researchers to modulate chaperone-mediated autophagy and stem cell fate with unprecedented precision. Its dual action on LAMP2A and Rab11 sets a new standard for experimental reproducibility and mechanistic insight in autophagy and stem cell biology research.
2-NBDG Glucose Uptake Assay Kit: Decoding Metabolic Plastici
2026-08-03
Explore how the 2-NBDG Glucose Uptake Assay Kit enables precise, non-radioactive analysis of cellular glucose metabolism, with a unique focus on metabolic plasticity and sorafenib resistance in hepatocellular carcinoma. This article offers deep scientific insight and practical guidance for advanced glucose metabolism research.
QX77 and the Future of Chaperone-Mediated Autophagy Research
2026-08-03
This thought-leadership article explores the mechanistic landscape of chaperone-mediated autophagy (CMA) and stem cell differentiation, highlighting the strategic role of QX77, a molecular chaperone activator from APExBIO. Bridging recent advances in mitophagy regulation with practical experimental guidance, it delivers a roadmap for translational researchers seeking reproducible control over autophagy pathways, particularly in lung disease and stem cell biology.
Imipramine in Research: Autophagy, Apoptosis, and Advanced A
2026-08-02
Imipramine, a classic tricyclic antidepressant, is powering breakthroughs in oncology and neurobiology labs through its dual modulation of autophagy and apoptosis. This article spotlights best-practice experimental workflows, troubleshooting tips, and the translational edge provided by APExBIO's research-grade Imipramine.
461 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page